Guidance
2 The technology
2 The technology
Technology |
UrgoStart (Urgo Medical) is an interactive dressing for treating diabetic foot ulcers and leg ulcers. It consists of a layer of open-weave polyester mesh impregnated with hydrocolloid polymers within a petroleum jelly known as technology lipido-colloid (TLC). It also contains nano-oligosaccharide factor (NOSF) and has an absorbent pad and a semi-permeable backing. There are 5 formats of the dressing and each comes in different sizes: UrgoStart Contact Layer, UrgoStart Non-Adhesive, UrgoStart Plus Pad, UrgoStart Border and UrgoStart Plus Border. |
Innovative aspects |
The TLC-NOSF layer is a combination of the patented TLC technology, which is intended to create a moist protective wound healing environment, and the NOSF, which inhibits protease activity, specifically matrix metalloproteinases, and this is claimed to accelerate healing. |
Intended use |
UrgoStart is intended for treating chronic wounds. The indications addressed in this evaluation are leg ulcers and diabetic foot ulcers. |
Costs |
UrgoStart has a typical list price of £4.28 per dressing. |
For more details, see the Urgo Medical website. |